ThromboGenics NV announced that the board has appointed long-time non-executive director Mr. Thomas Clay as its next chairman. The appointment, effective 15 June 2017, coincides with the retirement of ThromboGenics' current chairman of the board, Staf Van Reet, PhD. Thomas Clay is Vice-President of East Hill Management. He also serves as the Chairman and CEO of Golden Queen Mining Co. Ltd., and is a Director of the Clay Mathematics Institute.